US FDA Panel To Consider Compounding Ban For Makena’s Active Ingredient

 
• By Sue Sutter
  
Hydroxyprogesterone caproate molecule
Hydroxyprogesterone caproate may be headed for a compounding ban. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Review Pathways

More from Pathways & Standards